P&U Edronax Focus Group in U.K. Deemed Promotional
Executive Summary
Pharmacia & Upjohn's payment to physicians for attending a series of focus group meetings in the U.K. on the noradrenaline reuptake inhibitor Edronax was not appropriate, the U.K. Code of Practice Appeal Board recently ruled.